ghk cu injectable safety evidence GHK-Cu Side Effects: What Does the Research Say? Doctor Explains GHK-CU - Beverly Hills Rejuvenation

lowest tolerated dose Phase Step 2 Weeks Weeks 5-8 Cagrilintide Dose 0.5 mg/week Purpose Dose escalation Phase Step 3 Weeks Weeks 9-12 Cagrilintide Dose 1.0 mg/week Purpose GI side effects often peak here Phase Step 4 Weeks Weeks 13-16 Cagrilintide Dose 1.7 mg/week Purpose Approaching maintenance Phase Maintenance Weeks Weeks 17+ Cagrilintide Dose 2.4 mg/week Purpose Target dose used in late-stage study protocols Each step lasts 4 weeks

Of interest, IGF-IR mRNA is temporally consistent with the IGF-I expression, except from the mural granulose cells, where IGF-IR production is preserved, suggesting a paracrine/endocrine dependence for the IGF-I effects at this level[101]

For more severe symptoms, like pain, bloody stool, vomiting, and poor coordination, please seek medical attention immediately.

Hossenlopp P, Seurin D, Segovia B, Quinson B, Hardouin S, Binoux M